Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2.

Nielson CM, Liu CT, Smith AV, Ackert-Bicknell CL, Reppe S, Jakobsdottir J, Wassel C, Register TC, Oei L, Alonso N, Oei EH, Parimi N, Samelson EJ, Nalls MA, Zmuda J, Lang T, Bouxsein M, Latourelle J, Claussnitzer M, Siggeirsdottir K, Srikanth P, Lorentzen E, Vandenput L, Langefeld C, Raffield L, Terry G, Cox AJ, Allison MA, Criqui MH, Bowden D, Ikram MA, Mellström D, Karlsson MK, Carr J, Budoff M, Phillips C, Cupples LA, Chou WC, Myers RH, Ralston SH, Gautvik KM, Cawthon PM, Cummings S, Karasik D, Rivadeneira F, Gudnason V, Orwoll ES, Harris TB, Ohlsson C, Kiel DP, Hsu YH
J Bone Miner Res. 2016 31 (12): 2085-2097

PMID: 27476799 · PMCID: PMC5477772 · DOI:10.1002/jbmr.2913

MeSH Terms (21)

Animals Biopsy Bone Density Cancellous Bone Excitatory Amino Acid Transporter 1 Gene Expression Regulation Genetic Association Studies Genetic Predisposition to Disease Humans Linkage Disequilibrium Lumbar Vertebrae Mice Molecular Sequence Annotation Organ Size Osteoblasts Polymorphism, Single Nucleotide Quantitative Trait Loci Receptor, EphB2 Risk Factors Spinal Fractures Spine

Connections (1)

This publication is referenced by other Labnodes entities:

Links